October 29, 2018

Abortion groups want FDA to allow abortion pill use without medical supervision

Abortion groups want FDA to allow abortion pill use without medical supervision
The abortion lobby is planning to expand abortion access by seeking to change the FDA’s safety strategy for dispensing the abortion pill regimen known as RU486. Planned Parenthood and the abortion industry present abortion as “safe and simple,” but one look at forms they require women to sign reveals the real truth. Missed abortion, blood clots, infection and even death are among the risks associated with medication abortion. Despite these risks, the abortion lobby is pushing for “home use,” “mail order,” OTC, and “telabortion.”

The abortion pill regimen is made up of two drugs: Misoprostol and Mifeprex, which is currently regulated by the FDA under a system known as REMS, an acronym that stands for Risk Evaluation and Mitigation Strategies.  The REMS document states that, “Mifeprex must be dispensed to patients only in certain healthcare settings, specifically clinics, medical offices, and hospitals, by or under the supervision of a certified prescriber.” The pill’s manufacturer, Danco Laboratories, must “[e]nsure that Mifeprex is not distributed to or dispensed through retail pharmacies or other settings….”

Click here for more from Live Action News.